Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Efficacy, immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine (444563), in healthy infants
Rotavirus Vaccine
113808
NCT01171963
Infections, Rotavirus
Phase 3
 
March 2014

Powered by ideaPoint, Inc.